| |
1st Screening
|
2nd Screening
|
Validation
| | |
|---|
| |
Patients (n = 10)
|
Patients (n = 134)
|
HD (n = 24)
|
Patients (n = 70)
|
HD (n = 42)
|
|---|
|
Age
|
72.4 (3.53)
|
68.1 (10.4)
|
64.4 (8.03)
|
68.6 (10.3)
|
53.0 (4.57)
|
|
Male gender
|
9 (90)
|
106 (79.3)
|
21 (87.5)
|
54 (77.1)
|
25 (59.5)
|
|
Hypertension
|
6 (60)
|
88 (65.9)
|
1 (4.17)
|
45 (64.3)
|
N/A
|
|
Diabetes
|
3 (30)
|
35 (25.9)
|
3 (12.5)
|
17 (24.3)
|
N/A
|
|
Hyperlipidemia
|
3 (30)
|
36 (26.7)
|
1 (4.17)
|
22 (31.4)
|
N/A
|
|
Smoking
|
1 (10)
|
46 (34.1)
|
6 (25.0)
|
24 (34.3)
|
N/A
|
|
Stroke
|
10 (100)
|
129 (96.3)
|
0 (0)
|
67 (95.7)
|
0
|
|
Stroke etiology
| | |
-
| |
-
|
|
LAA
|
10 (100)
|
34 (21.5)
| |
29 (41.4)
| |
|
SVD
|
0 (0)
|
62 (39.2)
| |
18 (25.7)4
| |
|
CE
|
0 (0)
|
14 (8.9)
| |
(5.71)
| |
|
UD and others
|
0 (0)
|
24 (15.2)
| |
16 (23.9)
| |
|
Carotid stenosis >50%
|
10 (100)
|
31/102 (30.4)
|
N/A
|
38/60 (63.3)
|
N/A
|
- Baseline characteristics of subjects in 1st, 2nd and validation cohort are displayed. Data represents means (SD) for numerical data and n (%) for categorical data. CE, cardioembolism. HD, healthy donor. N/A, not assessed. LAA, large artery atherosclerosis. SVD, small vessel disease. UD, undetermined ethiology.
